ICON shareholders vote in favour of all resolutions at its Annual General Meeting

Business Wirevia The Motley Fool
Updated

ICON shareholders vote in favour of all resolutions at its Annual General Meeting

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General Meeting of the Company (AGM) held on 22nd July 2013 (which resolutions had all been recommended by the Board) were all duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders on 14th June 2013 and are available on the ICON plc website.

The final results of voting on each of the items submitted to a vote of shareholders during the AGM are as follows:

RESOLUTION
NUMBER

RESOLUTION

TOTAL NUMBEROF VOTES

VOTE FOR

VOTE AGAINST

VOTE WITHHELD

1.1

To re-elect Mr. Thomas Lynch

51,674,203

51,474,431

133,020

66,752

1.2

To re-elect Mr. Declan McKeon

51,674,203

51,506,997

100,445

66,761

1.3

To re-elect Prof. William Hall

51,674,203

51,517,884

89,558

66,761

2

To receive accounts and reports

51,674,203

51,409,116

8,517

256,570

3

To authorise the fixing of the auditors' remuneration

51,674,203

47,640,947

3,965,491

67,765

4

To authorise the Company to allot shares

51,674,203

44,580,855

7,013,214

80,134

5**

To disapply pre-emption rights

51,674,203

45,337,820

6,251,874

84,509

6**

To authorise the Company to make market purchases of shares

51,674,203

51,122,122

13,329

538,752


** Special Resolution. All resolutions are ordinary resolutions unless otherwise stated.

The statements made in this press release may contain forward-looking statements that involve a number of risks and uncertainties. In addition to the matters described in this press release, the ability to maintain large client contracts or enter into new contracts, maintain client relationships and the ability to manage the opening of new offices, the integration of new business mergers and acquisitions, as well as other risks and uncertainties detailed from time to time in reports filed with the US Securities and Exchange Commission by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the actual results achieved by ICON. ICON disclaims any intent or obligation to update these forward-looking statements.

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 78 locations in 37 countries and has approximately 10,170 employees. Further information is available at www.iconplc.com.

ICON/ICLR-F



ICON
Investor Relations
1-888-381-7923
or
Brendan Brennan
Chief Financial Officer
+ 353 -1-291-2000
or
Simon Holmes
EVP Investor Relations and Corporate Development
+ 353 -1-291-2000

KEYWORDS: United States Europe North America Ireland

INDUSTRY KEYWORDS:

The article ICON shareholders vote in favour of all resolutions at its Annual General Meeting originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement